IBDEI1TN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30495,0)
 ;;=M77.12^^135^1378^53
 ;;^UTILITY(U,$J,358.3,30495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30495,1,3,0)
 ;;=3^Lateral Epicondylitis,Left Elbow
 ;;^UTILITY(U,$J,358.3,30495,1,4,0)
 ;;=4^M77.12
 ;;^UTILITY(U,$J,358.3,30495,2)
 ;;=^5013305
 ;;^UTILITY(U,$J,358.3,30496,0)
 ;;=M79.1^^135^1378^61
 ;;^UTILITY(U,$J,358.3,30496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30496,1,3,0)
 ;;=3^Myalgia
 ;;^UTILITY(U,$J,358.3,30496,1,4,0)
 ;;=4^M79.1
 ;;^UTILITY(U,$J,358.3,30496,2)
 ;;=^5013321
 ;;^UTILITY(U,$J,358.3,30497,0)
 ;;=M79.7^^135^1378^39
 ;;^UTILITY(U,$J,358.3,30497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30497,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,30497,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,30497,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,30498,0)
 ;;=M80.08XA^^135^1378^1
 ;;^UTILITY(U,$J,358.3,30498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30498,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Vertebra Fx,Init Encntr
 ;;^UTILITY(U,$J,358.3,30498,1,4,0)
 ;;=4^M80.08XA
 ;;^UTILITY(U,$J,358.3,30498,2)
 ;;=^5013495
 ;;^UTILITY(U,$J,358.3,30499,0)
 ;;=M80.08XD^^135^1378^2
 ;;^UTILITY(U,$J,358.3,30499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30499,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Vertebra Fx,Subs Encntr
 ;;^UTILITY(U,$J,358.3,30499,1,4,0)
 ;;=4^M80.08XD
 ;;^UTILITY(U,$J,358.3,30499,2)
 ;;=^5013496
 ;;^UTILITY(U,$J,358.3,30500,0)
 ;;=M84.48XA^^135^1378^101
 ;;^UTILITY(U,$J,358.3,30500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30500,1,3,0)
 ;;=3^Pathological Fx,Oth Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,30500,1,4,0)
 ;;=4^M84.48XA
 ;;^UTILITY(U,$J,358.3,30500,2)
 ;;=^5014016
 ;;^UTILITY(U,$J,358.3,30501,0)
 ;;=M84.48XD^^135^1378^102
 ;;^UTILITY(U,$J,358.3,30501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30501,1,3,0)
 ;;=3^Pathological Fx,Oth Site,Subs Encntr
 ;;^UTILITY(U,$J,358.3,30501,1,4,0)
 ;;=4^M84.48XD
 ;;^UTILITY(U,$J,358.3,30501,2)
 ;;=^5014017
 ;;^UTILITY(U,$J,358.3,30502,0)
 ;;=M87.011^^135^1378^45
 ;;^UTILITY(U,$J,358.3,30502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30502,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Right Shoulder
 ;;^UTILITY(U,$J,358.3,30502,1,4,0)
 ;;=4^M87.011
 ;;^UTILITY(U,$J,358.3,30502,2)
 ;;=^5014658
 ;;^UTILITY(U,$J,358.3,30503,0)
 ;;=M87.012^^135^1378^42
 ;;^UTILITY(U,$J,358.3,30503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30503,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Left Shoulder
 ;;^UTILITY(U,$J,358.3,30503,1,4,0)
 ;;=4^M87.012
 ;;^UTILITY(U,$J,358.3,30503,2)
 ;;=^5014659
 ;;^UTILITY(U,$J,358.3,30504,0)
 ;;=M87.050^^135^1378^43
 ;;^UTILITY(U,$J,358.3,30504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30504,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Pelvis
 ;;^UTILITY(U,$J,358.3,30504,1,4,0)
 ;;=4^M87.050
 ;;^UTILITY(U,$J,358.3,30504,2)
 ;;=^5014679
 ;;^UTILITY(U,$J,358.3,30505,0)
 ;;=M87.051^^135^1378^44
 ;;^UTILITY(U,$J,358.3,30505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30505,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Right Femur
 ;;^UTILITY(U,$J,358.3,30505,1,4,0)
 ;;=4^M87.051
 ;;^UTILITY(U,$J,358.3,30505,2)
 ;;=^5014680
 ;;^UTILITY(U,$J,358.3,30506,0)
 ;;=M87.052^^135^1378^41
 ;;^UTILITY(U,$J,358.3,30506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30506,1,3,0)
 ;;=3^Idiopathic Aseptic Necrosis of Left Femur
 ;;^UTILITY(U,$J,358.3,30506,1,4,0)
 ;;=4^M87.052
 ;;^UTILITY(U,$J,358.3,30506,2)
 ;;=^5014681
 ;;^UTILITY(U,$J,358.3,30507,0)
 ;;=M87.111^^135^1378^74
 ;;^UTILITY(U,$J,358.3,30507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30507,1,3,0)
 ;;=3^Osteonecrosis d/t Drugs,Right Shoulder
